Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
27 announcements with these filters
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.
Procter & Gamble Hygiene and Health Care Ltd held its 62nd Annual General Meeting on September 8, 2026, to discuss financial statements, dividends, and director appointments.
Procter & Gamble Hygiene and Health Care Ltd has released its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026. This filing details the company's performance on ESG metrics.
P&G Hygiene announced its 62nd AGM for Sep 8, 2026. Agenda includes financial adoption, dividend, director appointments, and a ₹1,000 Cr material related party transaction.
Procter & Gamble Hygiene and Health Care Limited scheduled its 62nd Annual General Meeting for September 8, 2026. The meeting will address financial adoption and dividend declarations.
Procter & Gamble Hygiene and Health Care Limited scheduled its 62nd Annual General Meeting for September 8, 2026. The record date for dividend eligibility is September 1, 2026.
Procter & Gamble Hygiene and Health Care recommended a final dividend of Rs. 60 per equity share for FY 2025-26. The record date is set for September 1, 2026.
P&G Hygiene reported Q1 sales of ₹901 crore, up 5% year-on-year. Profit after tax stood at ₹126 crore for the period.
Procter & Gamble Hygiene & Healthcare Ltd reported revenue from operations of ₹891.5 Cr (-4.9% YoY) and net profit of ₹126.3 Cr (-34.3% YoY) for Q1 FY27.
Procter & Gamble Hygiene and Health Care recommended a final dividend of ₹60 per equity share for FY 2025-26. The record date is August 26, 2026.
Procter & Gamble Home Products acquired a 1.91% stake from Temple Trees Impex via an inter-se promoter transfer. This internal restructuring does not change overall promoter control.
Procter & Gamble Hygiene and Health Care Ltd announced the record date as August 26 2026 for its 62nd AGM and dividend. Dividend, if approved, will be paid by September 30 2026.
Procter & Gamble Hygiene & Health Care appointed Gopalakrishnan Kalianna as Sales Head effective Aug 1 2026. Rohini Venkateswaran is promoted to Senior Vice President‑Korea.
P&G Hygiene and Health Care scheduled a board meeting for July 29, 2026. The meeting will consider unaudited financial results for the quarter ended June 30, 2026.
P&G Hygiene reported FY26 sales of ₹4300cr (flat YoY) and PAT of ₹850cr (up 19%). Strategy focuses on 'irresistible superiority' in Feminine Care and Healthcare through innovation and productivity.
Procter & Gamble Hygiene and Health Care Ltd reported FY 2025-26 results showing flat sales growth and a 19% increase in Profit After Tax (PAT), focusing on productivity and brand superiority.
P&G Hygiene & Health Care named Mohit Pradhan VP, Category Leader for Feminine Hygiene, effective 1 Aug 2026. He succeeds Girish Kalyanaraman, who steps down on 1 July 2026.
Procter & Gamble Hygiene and Health Care recommended a final dividend of ₹60 per share for FY 2025-26. The record date is set for August 17, 2026.
Procter & Gamble Hygiene reported annual PAT of ₹857 crore, up 19% YoY. The Board recommended a total dividend of ₹255 per equity share for the fiscal.
Procter & Gamble Hygiene & Healthcare Ltd reported revenue from operations of ₹941.3 Cr (-5.1% YoY) and net profit of ₹153.1 Cr (-1.9% YoY) for Q4 FY26.
Procter & Gamble Hygiene reported its FY2026 audited financial results and recommended a dividend of Rs. 60 per share. Total dividend payout amounts to ₹194.76 Crore.
Procter & Gamble Hygiene appointed Srividya Srinivasan as CFO effective July 1, 2026. This follows the transition of current leadership to new regional roles within P&G.
Procter & Gamble Hygiene and Health Care scheduled its 62nd AGM for August 24, 2026. The record date for dividend eligibility is August 17, 2026.
Procter & Gamble Hygiene & Healthcare Ltd reported net profit of ₹302 Cr (+12.3% YoY) for Q3 FY26.